Tether's venture capital firm makes $200 million strategic investment in biotechnology company Blackrock Neurotech

According to BlockBeats, on April 29, biotechnology company Blackrock Neurotech announced that it had received a $200 million strategic investment from Tether Evo, a venture capital firm under the stablecoin issuer Tether. After this round of investment, Tether became the majority shareholder of Blackrock Neurotech. This investment will help Blackrock Neurotech fund the commercialization and promotion of its medical solutions and support its research and development work. (The Block)